Lawrence Blatt is the founder of Aligos Therapeutics. Aligos Therapeutics has raised $225M in total funding. Latest round: Series B.
Lawrence M. Blatt, Ph.D., M.B.A., co-founded Aligos Therapeutics and has served as its Chief Executive Officer and a member of its board of directors since February 2018. Prior to co-founding Aligos, he was the Global Head of Infectious Diseases and Vaccines at Janssen Pharmaceutical Companies of Johnson & Johnson. He also co-founded Alios BioPharma, Inc., serving as its CEO, President, and Director until its acquisition by Janssen.
Full founder directory · Investor directory · Company funding database · Fundraising library